Announcements are issued! A number of companies have issued announcements on major asset restructuring and the signing of major contracts
Macro and Micro Technology: Repurchase shares worth 25 million to 500,000 yuan
Macro Micro Technology recently announced that the company intends to repurchase shares worth 25 million yuan to 50 million yuan for equity incentives or employee stock ownership plans, or for the conversion of corporate bonds issued by listed companies that can be converted into **, and the repurchase ** does not exceed 4699 yuan shares (including 46.)$99 shares).
Chuling Information: It is planned to repurchase shares of 10 million to 20 million yuan]. ］
Chuling Information announced that the company intends to repurchase shares worth 10 million yuan to 20 million yuan, in order to maintain the company's value and shareholders' rights, the repurchase ** does not exceed 1500 yuan shares.
Xinneng Taishan: It is planned to sign an entrusted management agreement with Huaneng (Nanjing) Asset Management Co., Ltd. with Energy and Transportation Co., Ltd.
Xinneng Taishan issued an announcement saying that the company ("Trustees") plans to cooperate with Huaneng Energy Transportation Industry Holdings"Energy Transportation Companies"or"Participants"Signed the "Huaneng (Nanjing) Asset Management Entrusted Management Agreement". (According to the agreement, the energy and transportation company will entrust Huaneng (Nanjing) Asset Management*** hereinafter referred to as.)"Huaneng Assets"or"Target company"Undertake Huaneng (Nanjing) Asset Management***hereinafter referred to as"Huaneng Assets"or"Target company") day-to-day management functions. The entrustment period is from January 1, 2024 to December 31, 2024, and is responsible for the overall management of Huaneng Assets.
Beilu Pharmaceutical: Plans to acquire 80% equity of Chengde Tianyuan Pharmaceutical].
Hokuriku Pharmaceutical announced that the company has entered into a joint venture with Jinan Sinopharm Group Co., Ltd"Jinan Chinese Medicine"，002636.SZ), Chengde Tianyuan Pharmaceutical Co., Ltd. ***"Tian Yuan Pharmaceutical"or"Target company"), Zhou Yinjun and Tian Yuan Enterprise Management Consulting Services Weichang Manchu Mongolian Autonomous County Partnership (Limited Partnership) ("Tian Yuan Enterprise Management"A contract was signed. (Beilu Pharmaceutical announced that the company and Jinan Sinopharm Group shares.)"Jinan Chinese Medicine"，002636.SZ), Chengde Tianyuan Pharmaceutical Co., Ltd. ***"Tian Yuan Pharmaceutical"or"Target company"), Zhou Yinjun and Tian Yuan Enterprise Management Consulting Services Weichang Manchu Mongolian Autonomous County Partnership (Limited Partnership) ("Tian Yuan Enterprise Management"Signed the "Letter of Intent for the Transfer of Chengde Tianyuan Pharmaceutical Shares", intending to acquire Chengde Tianyuan Pharmaceutical Shares with its own funds"Chengde Tianyuan"or"Target company"80% equity.
The content of this article is public information based on statistical data and does not constitute advice or a basis for buying or selling.